Effect of High Frequency Chest Wall Oscillation Vests on Spirometry Measurements - Completed
ongoing trials trial from www.clinicaltrials.gov
Details- 2018
- International Biophysics Corporation
Pilot E2 for Hypogonadal Women With CFBD - Phase 4 - Not yet recruiting
ongoing trials trial from www.clinicaltrials.gov
Details- 2018
- Emory University
Glycerol Phenylbutyrate Corrector Therapy For CF (Cystic Fibrosis) - Phase 1|Phase 2 - Recruiting
ongoing trials trial from www.clinicaltrials.gov
Details- 2018
- National Jewish Health|University of Alabama at Birmingham|Children's Hospital of Philadelphia|Johns Hopkins University|Horizon Pharma Ireland, Ltd., Dublin Ireland
OPTION: A Trial to Assess the Safety & Efficacy of MS1819 in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis - Phase 2 - Not yet recruiting
ongoing trials trial from www.clinicaltrials.gov
Details- 2018
- AzurRx BioPharma, Inc.
Effect of Aerobic Exercise on Insulin Resistance in Individuals With Cystic Fibrosis - Not yet recruiting
ongoing trials trial from www.clinicaltrials.gov
Details- 2018
- Universidade Federal do Rio Grande do Norte|Universidade Estadual da Paraiba
A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of VX-445 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
ongoing trials trial from www.clinicaltrials.gov
Details- 2018
PPIs and Fat Absorption in CF and EPI - Phase 2 - Recruiting
ongoing trials trial from other registries
Details- 2018
- Children's Hospital of Philadelphia|Chiesi USA
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-445 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del Mutation (F/F)
ongoing trials trial from www.clinicaltrials.gov
Details- 2018
Study to Evaluate the Safety & Tolerability of MRT5005 Administered by Nebulization in Adults With Cystic Fibrosis - Phase 1|Phase 2 - Not yet recruiting
ongoing trials trial from other registries
Details- 2018
- Translate Bio, Inc.
A Phase 3 Study of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Heterozygous for the F508del Mutation and a Minimal Function Mutation (F/MF) - Phase 3 - Not yet recruiting
ongoing trials trial from www.clinicaltrials.gov
Details- 2018
- Vertex Pharmaceuticals Incorporated